Ineligible Issuer Status. The Company is not an “ineligible issuer” in connection with the offering of the Shares pursuant to Rules 164, 405 and 433 under the Securities Act.
Appears in 7 contracts
Samples: Open Market Sale (VBI Vaccines Inc/Bc), Open Market Sale (Avalon GloboCare Corp.), Open Market Sale Agreement (Constellation Pharmaceuticals Inc)
Ineligible Issuer Status. The Company is not an “ineligible issuer” in connection with the offering of the Shares Securities pursuant to Rules 164, 405 and 433 under the Securities Act.
Appears in 6 contracts
Samples: Securities Purchase Agreement (ImmunityBio, Inc.), Securities Purchase Agreement (ImmunityBio, Inc.), Securities Purchase Agreement (ImmunityBio, Inc.)
Ineligible Issuer Status. The Company was not and is not an “ineligible issuer” issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Shares pursuant to Rules 164, 405 and 433 under the Securities ActShares.
Appears in 3 contracts
Samples: Terms Agreement (Global Medical REIT Inc.), Sales Agreement (Global Medical REIT Inc.), Terms Agreement (Global Medical REIT Inc.)
Ineligible Issuer Status. The Company is not an “ineligible issuer” in connection with the offering of the Shares pursuant to Rules 164, 405 and 433 under the Securities Act.
Appears in 3 contracts
Samples: Waitr Holdings Inc., Waitr Holdings Inc., Waitr Holdings Inc.
Ineligible Issuer Status. The Company is not an “ineligible issuer” in connection with the offering of the Shares and Forward Settlement Shares pursuant to Rules 164, 405 and 433 under the Securities Act.. 276938411 v5
Appears in 1 contract
Samples: Postal Realty Trust, Inc.
Ineligible Issuer Status. The Company is not an “ineligible issuer” in connection with the offering of the Shares Securities pursuant to Rules 164, 405 and 433 under the Securities Act of 1933, as amended (the “Securities Act”).
Appears in 1 contract
Samples: Securities Purchase Agreement (Enliven Therapeutics, Inc.)
Ineligible Issuer Status. The Company is not an “ineligible issuer” in connection with the offering of the Shares Securities pursuant to Rules Rule 164, 405 and 433 under the Securities Act.
Appears in 1 contract
